Related Experiment Video
Updated: May 12, 2025

06:11
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
9.7K
A novel tumor budding and cell nest size-based grading system outperforms conventional methods in vulvar squamous
Xiangyu Chen1, Shuang Song1,2, Haiyan Shi1
1Department of Surgical Pathology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China.
Summary
The tumor budding and nest size (TBNS) grading system shows promise for predicting vulvar squamous cell carcinoma (VSCC) outcomes. High TBNS grade correlates with poorer survival and aggressive features in VSCC patients.
Area of Science:
- Oncology
- Pathology
Background:
- The tumor budding and tumor cell nest size (TBNS) grading scheme is an emerging prognostic indicator for squamous cell carcinoma (SCC).
- Its prognostic significance in vulvar SCC (VSCC) is not well-established.
Purpose of the Study:
- To evaluate the prognostic value of the TBNS grading system in surgically resected vulvar squamous cell carcinoma (VSCC).
- To compare the efficacy of the TBNS grading system against conventional grading systems in VSCC.
Main Methods:
- Applied the TBNS grading system to a cohort of 62 surgically resected VSCC cases.
- Excluded patients receiving neoadjuvant chemotherapy or with FIGO stage IA disease.
- Analyzed associations between TBNS grade, clinicopathologic features, overall survival (OS), and disease-free survival (DFS).
Main Results:
- High TBNS grade was significantly associated with reduced OS and DFS in VSCC.
- High TBNS grade correlated with adverse features: lymphovascular invasion, perineural involvement, lymph node metastasis, and advanced FIGO stage.
- Multivariate analysis confirmed TBNS grade 3 as an independent predictor of reduced DFS.
Conclusions:
- The TBNS grading system is a promising prognostic indicator for VSCC.
- The TBNS system demonstrated superior prognostic performance compared to conventional grading systems in this cohort.
- Further validation in larger cohorts is recommended to broaden clinical application.

